10
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Conversion of Thyroxine to Triiodothyronine and Reverse Triiodothyronine in Human Placenta and Fetal Membranes

      research-article
      , , ,
      Hormone Research in Paediatrics
      S. Karger AG
      Thyroxine conversion, Human placenta, Chorion

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Conversion of thyroxine (T<sub>4</sub>) to 3,5,3’-triiodothyronine (T<sub>3</sub>) and reverse 3,3’,5’-triiodothyronine (rT<sub>3</sub>) was measured in vitro in human placenta and fetal membranes. T<sub>4</sub> (5 µg/ml) was incubated in 0.15 mol/l phosphate buffer with tissue homogenates for 2 h at 37°C, and the T<sub>3</sub> and rT<sub>3</sub> generated were determined in ethanol extract using RIA methods. The placenta and chorion homogenates converted more T<sub>4</sub> to T<sub>3</sub> than to rT<sub>3</sub>; the placenta was more active than the chorion. In both tissues the highest converting activity was found in microsomal fractions.

          Related collections

          Author and article information

          Journal
          HRE
          Horm Res Paediatr
          10.1159/issn.1663-2818
          Hormone Research in Paediatrics
          S. Karger AG
          1663-2818
          1663-2826
          1980
          1980
          25 November 2008
          : 12
          : 5
          : 253-259
          Affiliations
          Department of Medicine, Clinical Hospital, Zagreb
          Article
          179128 Horm Res 1980;12:253–259
          10.1159/000179128
          7399397
          8ae7bf01-ab1d-4e3d-b5cf-d3622048925e
          © 1980 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 20 September 1979
          : 05 January 1980
          Page count
          Pages: 7
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Chorion,Thyroxine conversion,Human placenta

          Comments

          Comment on this article